China Myeloma Digital Network

When Facing Multiple Myeloma, You Are Not Alone

CMDN is a nonprofit, patient-founded organization. We provide evidence-based myeloma information and unbiased guidance for international patients seeking approved CAR-T therapies in China. Our comprehensive patient navigation services are provided completely free of charge.

100% Evidence-Based Guidelines

Medical facts 100% sourced from NCCN, CSCO, IMWG guidelines and official CDE registries.

CAR-T in China (Nonprofit Guide)

A practical, evidence-based guide to prices, hospital tiers, clinical facts, and common scams for international families considering CAR-T in China.

Independent Patient Navigation

Free, patient-first guidance designed to reduce information gaps, avoid unnecessary intermediary markups and help patients ask hospitals the right questions.

Knowledge synchronized with leading authorities
National Comprehensive Cancer Network (NCCN)International Myeloma Foundation (IMF)Multiple Myeloma Research Foundation (MMRF)International Myeloma Working Group (IMWG)European Myeloma Network (EMN)mSMART

"In my 8th year living with myeloma, I watched my daughter get into college."

Patient, Diagnosed 2018

"I cried during my first chemo, but now my monthly visits are routine. As long as I follow my treatment plan, life is still beautiful."

Patient, Maintenance Therapy

"Relapse is not the end. Through CMDN, I enrolled in a CAR-T clinical trial and achieved complete remission."

Patient, Relapsed/Refractory
Medical science is constantly advancing, making long-term survival a reality. Bookmark this site to stay connected with authoritative guidelines, clinical trials, and patient support resources.
Explore CAR-T in China